DCF — PIEDMONT ATHENS REGIONAL MEDICAL CE
Enterprise Value: $-335.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-335.2M
Enterprise Value
$-120.8M
PV of Cash Flows
$-214.4M
PV of Terminal Value
$-345.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $648.7M | $-12.8M | -2.0% | $-40.3M | $-36.6M |
| Year 2 | $668.2M | $-6.5M | -1.0% | $-34.8M | $-28.8M |
| Year 3 | $688.2M | $0.2M | 0.0% | $-29.0M | $-21.8M |
| Year 4 | $708.9M | $3.7M | 1.0% | $-26.3M | $-18.0M |
| Year 5 | $730.1M | $5.6M | 1.0% | $-25.3M | $-15.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-335.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$629.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.024774084125613507
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5